Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
LOS ANGELES, July 22, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises IBM, (“IBM" or the "Company") (NYSE: IBM) investors that the firm has initiated an investigation into possible securities...
-
LOS ANGELES, July 22, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Primoris Services Corporation, (“Primoris” or the "Company") (NYSE: PRIM) investors of a class action on behalf of...
-
LOS ANGELES, July 22, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises HCA Healthcare, Inc., (“HCA" or the "Company") (NYSE: HCA) investors that the firm has initiated an investigation into...
-
LOS ANGELES, July 21, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Immix Biopharma, (“Immix" or the "Company") (NASDAQ: IMMX) investors that the firm has initiated an investigation into...
-
LOS ANGELES, July 21, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Nano-X Imaging Ltd., (“Nano-X” or the "Company") (NASDAQ: NNOX) investors of a class action on behalf of investors that...
-
LOS ANGELES, July 21, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Microsoft Corporation, (“Microsoft” or the "Company") (NASDAQ: MSFT) investors of a class action on behalf of investors...
-
LOS ANGELES, July 21, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Black Rock Coffee, (“Black Rock” or the "Company") (NASDAQ: BRCB) investors of a class action on behalf of investors that...
-
LOS ANGELES, July 21, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Via Transportation, Inc., (“VIA” or the "Company") (NYSE: VIA) investors of a class action on behalf of investors that...
-
LOS ANGELES, July 21, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Erasca, Inc., (“Erasca” or the "Company") (NASDAQ: ERAS) investors of a class action on behalf of investors that bought...
-
LOS ANGELES, July 21, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises ADMA Biologics, Inc., (“ADMA” or the "Company") (NASDAQ: ADMA) investors of a class action on behalf of investors that...